Trial Profile
A phase II trial of S-1 and concurrent radiotherapy plus S-1 chemotherapy for peri-ampullar carcinoma after radical excision
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2013
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 14 Jun 2011 New trial record